Clinical Trial Update: Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim [Phase 3]

View source ↗

Summary

Phase III study comparing EP2006 to filgrastim in patients with chemotherapy-induced neutropenia and breast cancer, assessing efficacy and safety; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Neutropenia

Drugs mentioned

• EP2006
• Filgrastim (filgrastim)

Snippet

Sponsor: Sandoz | Conditions: Chemotherapy Associated Neutropenia, Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-04-07